NGFR p75 Monoclonal Antibody

Nerve growth factor receptor contains an extracellular domain containing four 40-amino acid repeats with 6 cysteine residues at conserved positions followed by a serine/threonine-rich region, a single transmembrane domain, and a 155-amino acid cytoplasmic domain. The cysteine-rich region contains the nerve growth factor binding domain.

Introducing the NGFR P75 Monoclonal Antibody, a cutting-edge scientific tool designed to revolutionize research in the field of neurobiology. This highly specific antibody is meticulously engineered to target the NGFR P75 protein, a crucial marker for neural stem cells and neurons.

Crafted with utmost precision, the NGFR P75 Monoclonal Antibody exhibits exceptional affinity and selectivity, enabling accurate detection and quantification of NGFR P75 expression in various biological samples. Its unrivaled sensitivity ensures reliable and reproducible results, empowering researchers to delve deeper into the intricate mechanisms underlying neural development and regeneration.

The NGFR P75 Monoclonal Antibody boasts an innovative formulation, meticulously optimized to minimize non-specific binding and background noise, thereby enhancing signal-to-noise ratios and facilitating precise data interpretation. Its robust performance across a wide range of experimental techniques, including immunohistochemistry, immunofluorescence, and Western blotting, ensures versatility and compatibility with diverse research applications.

Furthermore, this antibody is manufactured in strict adherence to rigorous quality control standards, guaranteeing batch-to-batch consistency and reproducibility. Its exceptional stability and long shelf life ensure optimal performance and reliability, even under demanding experimental conditions.

In summary, the NGFR P75 Monoclonal Antibody represents a breakthrough in neurobiology research, offering researchers an invaluable tool to unravel the complexities of neural development and regeneration. With its exceptional specificity, sensitivity, and versatility, this antibody is poised to accelerate scientific discoveries and pave the way for novel therapeutic interventions in neurological disorders.